UPDATE: Morgan Stanley Reiterates On IHS Following Solid Q2 Results

In a report published Friday, Morgan Stanley analyst Suzanne E. Stein reiterated an Equal-Weight rating on

, and raised the price target from $118.00 to $129.00. In the report, Morgan Stanley noted, “IHS has among the most attractive business models in our coverage: proprietary products with high customer retention, strong cash conversion rates, and a long history of growth. At current levels, shares seem richly valued relative to our current DCF base case valuation and on a multiple basis. Revenue and margin growth should accelerate as the macro outlook improves and the company achieves acquisition related synergies and efficiencies from platform investments.” IHS closed on Thursday at $136.54.